Articles from Adverse Event Reporting News (March 25, 2008)

Title	Author	Type	Words
AHRQ offers help creating 'pill card' to reduce adverse events.		Brief article	227
Amgen, Wyeth warn of infection risk for Enbrel.		Brief article	168
Blood storage impacts survival rate.			653
Byetta associated with acute pancreatitis.		Report	691
China orders tighter controls on heparin production; FDA establishes permanent presence in China.			807
Committee backs curbs on anemia drugs.			564
Drug trial oversight needs U.S. probe, lawmakers say.			387
FDA calls Medtronic drug pump warning Class I.		Brief article	210
FDA identifies contaminant in heparin as inspections begin at U.S. border; Braun recalls 23 lots.	Mashaw, Rebecca		748
FDA issues alert on Tussionex.			442
FDA seeks new warning on anesthetic.		Brief article	191
FDA updates mortality data for AneuRx stent graft.			644
FDA warns of liver toxicity with Prezista.		Brief article	174
FDA warns of stroke risk with Spiriva.			194
FDAAA of 2007 to require more trial information at clinicaltrials.gov.	Pickett, Joseph		503
Health Canada, Novartis warn of risks to patients taking Sebivo and Pegasys.			392
HHS Secretary appoints new members to AHRQ advisory council.		Brief article	208
Jury awards $40M to patient harmed by monitor.		Brief article	219
Lilly email discussed unapproved use of Zyprexa.			928
Many Americans self-medicate: study.		Brief article	205
MedDRA to become implemented in WHO's Vigibase.			327
Parents reject vaccines due to fears of adverse effects.			904
PediaCol lots contaminated, Health Canada says.		Brief article	82
REMS frequency seen increasing under FDAAA 2007, former chief counsel says.	Pickett, Joseph		494
Tegretol carries risk of serious skin conditions in Asian patients.			385
UCB recalls Neupro Parkinson's drug.		Brief article	153